KRUPAL PATEL: Open Payments
NPI 1093401853 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 25 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $204 |
| Sumitomo Pharma America, Inc. | 8 | $146 |
| TOLMAR, INC. | 3 | $87 |
| Endo USA, Inc. | 4 | $85 |
| Ferring Pharmaceuticals Inc. | 4 | $82 |
| 180 Medical, Inc. | 2 | $46 |
| UROGEN PHARMA, INC. | 1 | $25 |
Products named: AMS 700, ORGOVYX, AVEED, ADSTILADRIN, SpaceOAR VUE System - 10mL, ELIGARD, GEMTESA, JATENZO.
Industry payments across MD — which companies pay providers there.
